Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 04, 2025
Jabil Inc. announced the acquisition of Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) specializing in early stage, clinical, and commercial volume aseptic filling, lyophilization, and oral solid...
read more
Marker Therapeutics has announced the appointment of Nadia Agopyan, Ph.D., RAC as Vice President of Regulatory Affairs, effective August 15.
"We are pleased to welcome a professional of Nadia's caliber and senior leadership experience to Marker," ...
read more
Friday, November 06, 2015
TapImmune, a clinical-stage immune-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, announced today that it has relocated its ...
read more
IMS Health and Reltio have announced that IMS Health is offering Reltio Cloud with its Nexxus™ Commercial Application Suite and IMS One™ platform. Through the alliance, IMS Health will offer life sciences organizations new options for fast, scalable ...
read more
Tuesday, February 20, 2018
Sinclair Research announced new operational leadership with the arrival of Michael Eliel as senior director of operations and Anthony Rohr as consultant for special projects.
read more
Thursday, August 03, 2023
DNAnexus, a provider of cloud-based genomic and biomedical data access and companion analysis software, announced a collaboration with BigOmics Analytics, a Swiss biomedical data analysis company.
read more
Ofichem has unified its business divisions under a single brand identity, announcing that all operations will now trade under the Ofichem name. The move consolidates several long-standing brands — including Ofichem BV, Ofipharma, Ofimedicine, ...
read more
Clinipace has hired four operational, therapeutic, and medical experts to bolster the company’s global strategic development capabilities and medical expertise.
read more
Stevanato Group is preparing to open its Technology Excellence Center in Boston (US TEC), Massachusetts.
read more
Astellas Pharma Inc. announced that the FDA has placed a clinical hold on the FORTIS Phase 1/2 trial following the occurrence of a serious adverse event (SAE) of peripheral sensory neuropathy in one of the trial participants.
read more
Piramal is providing Bolt with the supply of both the BDC-1001 ISAC drug substance and the drug product for Bolt's ongoing Phase 1/2 clinical study in cancer patients.
read more
Monday, September 14, 2020
Valneva announced the signing of a new contract, lasting up to three years, with the U.S. government DoD for the supply of its Japanese encephalitis vaccine IXIARO.
read more
Wednesday, October 05, 2022
Absolute Biotech has launched as a unified company joining together leading antibody-centric brands from around the world.
read more
NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. Findings from this research are vital to NIAID’s efforts to advance vaccines, drugs, and ...
read more
Saturday, September 25, 2021
Quell Therapeutics, a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announced it has entered a collaboration with the Cell and Gene Therapy Catapult (CGT Catapult). The ...
read more